Pacific Biosciences of California Inc
PACB
Market Cap$342.1M
Close$
$5.61
383.4% upside
Current Fair Value
383.4% upsideUndervalued by 383.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $342.10 Million |
|---|---|
| Enterprise Value | $997.94 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.13 |
| Beta | 2.1 |
| Outstanding Shares | 296,858,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.51 |
|---|---|
| PEG | -0.12 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.55 |
| Enterprise Value to EBIT | -1.5 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 7.8 |
Revenue Sources
No data
Insider Trades
ESG Score
No data